Eli Lilly (NY:LLY)

1,041.51 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss ↗

Today 7:30 EST

Arrowhead Pharmaceuticals said Tuesday its gene-silencing approach almost doubled the four-month weight-loss with tirzepatide.

Via Investor's Business Daily

Motley Fool Money: Stock Market Naughty and Nice List ↗

Today 0:53 EST

There were nice companies and great CEOs in 2025, but also some duds. We discuss the stocks on each list and end by going shopping for stocks.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly Heads Toward A Defining 2026 — Can It Stay Ahead Of Novo Nordisk In The GLP-1 Showdown? ↗

Today 0:49 EST

Several clinical readouts and regulatory decisions are scheduled for Eli Lilly in 2026.

Via Stocktwits

Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗

January 05, 2026

The development comes as attention remains on Hims’ longer-term business expansion initiatives.

Via Stocktwits

Novo Nordisk Offers Oral Wegovy Pill At $149 A Month Following FDA’s Approval In December: Retail Tells Shorts ‘It’s Time To Give Up’ ↗

January 05, 2026

Via Stocktwits

MarketBeat Week in Review – 12/29 - 01/02 ↗

January 03, 2026

Via MarketBeat

2 Cash-Producing Stocks to Keep an Eye On and 1 We Ignore

January 05, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Prediction: The S&P 500 $1 Trillion Club Will Double Between 2026 and 2030 ↗

January 05, 2026

Several companies could see massive gains by 2030 to join the vaunted club.

Via The Motley Fool

Topics Stocks

The 2026 Blueprint: Five Core Stocks to Anchor Your Portfolio in a Year of AI Realization

January 05, 2026

As we cross the threshold into 2026, the financial markets have entered a sophisticated new phase. The "AI Gold Rush" of 2024 and 2025 has matured into what analysts are calling the "Era of AI...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Should Investors Be Worried That the "Magnificent Seven" Make Up 35% of the S&P 500? ↗

January 05, 2026

At the very least, investors should be concerned. There's a way to avoid the problem, though.

Via The Motley Fool

Topics Stocks

Top S&P500 movers in Monday's session ↗

January 05, 2026

Via Chartmill

Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗

January 05, 2026

Via MarketBeat

Topics Artificial Intelligence Death

Bank of America Issues 2026 'Priced for Perfection' Warning: Why the S&P 500 Faces a High-Stakes 'Air Pocket'

January 05, 2026

As the financial world rings in 2026, a sobering forecast from one of Wall Street’s most influential institutions has sent a ripple of caution through the markets. Bank of America (NYSE: BAC) Global...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Priced for Perfection: Bank of America Issues Stark Warning on S&P 500 Valuation for 2026

January 05, 2026

As the calendar turns to 2026, the euphoria that propelled the stock market through three consecutive years of double-digit gains is facing a sobering reality check. Bank of America (NYSE: BAC) has...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever ↗

January 05, 2026

Via MarketBeat

Eli Lilly: Strength Meets GLP‑1 Access Momentum ↗

January 05, 2026

Eli Lilly's stock remains robust at $1,080.36 amid positive market developments, strong GLP-1 access momentum, and heightened investor interest ahead of key earnings announcements.

Via Talk Markets

Is It Time to Dump Your Shares of Eli Lilly? ↗

January 05, 2026

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Via The Motley Fool

January 04, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

4 Stocks to Buy in January That Could Join Nvidia in the $1 Trillion Club by 2030 ↗

January 04, 2026

Visa, ExxonMobil, Oracle, and Netflix have multi-year compounding potential for patient investors.

Via The Motley Fool

Topics Artificial Intelligence

Prediction: These Will Be the Biggest Stock Splits for 2026 ↗

January 03, 2026

Plenty of well-known companies seem ripe for stock splits -- though you shouldn't really care.

Via The Motley Fool

The Great 2026 Rebalancing: Institutional Giants Pivot from AI Hype to Industrial Execution

January 02, 2026

As the opening bell rang for the first trading session of 2026, the financial world witnessed the commencement of what analysts are calling "The Great Rebalancing." Institutional fund managers,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Beyond the Bot: 2026 Marks the Great Rebalancing as Investors Pivot from AI Hype to Tangible Growth

January 02, 2026

As the opening bell rings on January 2, 2026, the financial landscape looks fundamentally different from the AI-crazed atmosphere of the previous two years. The "AI Infrastructure Fever" that dominated...

Via MarketMinute

Topics Artificial Intelligence Economy

The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls

January 02, 2026

Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...

Via MarketMinute

Topics Economy Intellectual Property World Trade

The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026

January 02, 2026

As the calendar turns to 2026, the landscape for weight-loss and diabetes medication has been fundamentally transformed. What began two years ago as a "wild west" of $1,000-a-month list prices and...

Via MarketMinute

Topics Economy Intellectual Property

S&P 500 Tests Critical Support Levels as 2026 Kicks Off Under Technical Pressure

January 02, 2026

The S&P 500 (INDEXSP:.INX) entered the new year on a tenuous footing, grappling with a rare four-session losing streak that capped off an otherwise stellar 2025. After finishing the final trading day...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

$100 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today ↗

January 02, 2026

Via Benzinga

Alphabet’s Golden Year: Inside the 2025 Rally and the Future of the AI Giant

January 02, 2026

As we enter 2026, the narrative surrounding the world’s most dominant information gateway has shifted from one of existential threat to unprecedented strength. Alphabet Inc. (NASDAQ: GOOGL / GOOG) has...

Via PredictStreet

Topics Artificial Intelligence Initial Public Offering

2 S&P 500 Stocks with Impressive Fundamentals and 1 We Avoid

January 01, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis

January 01, 2026

In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position...

Via TokenRing AI

Topics Artificial Intelligence

The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery

January 01, 2026

The landscape of biological science underwent a seismic shift in November 2024, when Google DeepMind, a subsidiary of Alphabet Inc. (NASDAQ: GOOGL), officially released the source code and model...

Via TokenRing AI

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.